These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 19631535)
41. Recent news reports suggest that the cholesterol medicine Zetia doesn't work. Should I stop taking my prescription? Johns Hopkins Med Lett Health After 50; 2008 Apr; 20(2):8. PubMed ID: 18705145 [No Abstract] [Full Text] [Related]
42. [Ezetimibe=cost effectiveness. Science or a debate contribution from MSD?]. Lindberg M Ugeskr Laeger; 2008 Sep; 170(38):2987; author reply 2988. PubMed ID: 18816890 [No Abstract] [Full Text] [Related]
43. The Zetia challenge: an update. Johns Hopkins Med Lett Health After 50; 2009 Apr; 21(2):6. PubMed ID: 19489149 [No Abstract] [Full Text] [Related]
45. A practical method for targeted library design balancing lead-like properties with diversity. Stocks MJ; Wilden GR; Pairaudeau G; Perry MW; Steele J; Stonehouse JP ChemMedChem; 2009 May; 4(5):800-8. PubMed ID: 19360802 [TBL] [Abstract][Full Text] [Related]
46. Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation". Westerink J; Visseren FL Circulation; 2009 Sep; 120(9):e66; author reply e69-70. PubMed ID: 19720942 [No Abstract] [Full Text] [Related]
47. Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation. Keller M; Teng S; Bernhardt G; Buschauer A ChemMedChem; 2009 Oct; 4(10):1733-45. PubMed ID: 19672917 [TBL] [Abstract][Full Text] [Related]
48. Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation". Settergren M; Rydén L; Pernow J Circulation; 2009 Sep; 120(9):e68; author reply e69-70. PubMed ID: 19720944 [No Abstract] [Full Text] [Related]
49. Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation". Tershakovec AM; Veltri EP; Pasternak RC Circulation; 2009 Sep; 120(9):e67; author reply e69-70. PubMed ID: 19720943 [No Abstract] [Full Text] [Related]
50. PDZ-domain-directed basolateral targeting of the peripheral membrane protein FRMPD2 in epithelial cells. Stenzel N; Fetzer CP; Heumann R; Erdmann KS J Cell Sci; 2009 Sep; 122(Pt 18):3374-84. PubMed ID: 19706687 [TBL] [Abstract][Full Text] [Related]
51. Novel syntheses of azetidines and azetidinones. Brandi A; Cicchi S; Cordero FM Chem Rev; 2008 Sep; 108(9):3988-4035. PubMed ID: 18781723 [No Abstract] [Full Text] [Related]
52. Increased epistaxis with use of ezetimibe/simvastatin. Shah B; McAllister A; Davidson TM Ann Pharmacother; 2009 Sep; 43(9):1545. PubMed ID: 19671801 [No Abstract] [Full Text] [Related]
54. An assay to monitor the membrane integration of single-span proteins. Krumpe K; Rapaport D Methods Mol Biol; 2013; 1033():301-6. PubMed ID: 23996185 [TBL] [Abstract][Full Text] [Related]
55. Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family. Borrmann T; Abdelrahman A; Volpini R; Lambertucci C; Alksnis E; Gorzalka S; Knospe M; Schiedel AC; Cristalli G; Müller CE J Med Chem; 2009 Oct; 52(19):5974-89. PubMed ID: 19731917 [TBL] [Abstract][Full Text] [Related]
56. 5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103). Hutchinson JH; Li Y; Arruda JM; Baccei C; Bain G; Chapman C; Correa L; Darlington J; King CD; Lee C; Lorrain D; Prodanovich P; Rong H; Santini A; Stock N; Prasit P; Evans JF J Med Chem; 2009 Oct; 52(19):5803-15. PubMed ID: 19739647 [TBL] [Abstract][Full Text] [Related]
57. Synthesis of trans-4-aryl-3-(omega-chloroalkyl) -2-azetidinones. Dejaegher Y; De Kimpe N Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet; 2001; 66(4):53-6. PubMed ID: 15954263 [No Abstract] [Full Text] [Related]
58. Position 5.46 of the serotonin 5-HT2A receptor contributes to a species-dependent variation for the 5-HT2C agonist (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: impact on selectivity and toxicological evaluation. Miller KJ; Wu GY; Varnes JG; Levesque P; Li J; Li D; Robl JA; Rossi KA; Wacker DA Mol Pharmacol; 2009 Dec; 76(6):1211-9. PubMed ID: 19767451 [TBL] [Abstract][Full Text] [Related]
59. Structural and biophysical characterization of XIAP BIR3 G306E mutant: insights in protein dynamics and application for fragment-based drug design. Moore CD; Wu H; Bolaños B; Bergqvist S; Brooun A; Pauly T; Nowlin D Chem Biol Drug Des; 2009 Sep; 74(3):212-23. PubMed ID: 19660030 [TBL] [Abstract][Full Text] [Related]
60. Characterization of FIBCD1 as an acetyl group-binding receptor that binds chitin. Schlosser A; Thomsen T; Moeller JB; Nielsen O; Tornøe I; Mollenhauer J; Moestrup SK; Holmskov U J Immunol; 2009 Sep; 183(6):3800-9. PubMed ID: 19710473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]